Welcome to CDC stacks | Hepatitis C & injection drug use - 30626 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Hepatitis C & injection drug use
  • Published Date:
    February 2015
  • Language:
    English
Filetype[PDF-595.35 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Keywords:
  • Description:
    What is Hepatitis C? -- What are the symptoms? -- Should I get tested? -- How is Hepatitis C spread among people who inject drugs? -- Are there other ways Hepatitis C can spread? -- Can Hepatitis C be prevented? -- Cleaning equipment does not kill the Hepatitis C virus. -- Can Hepatitis C be treated? -- Can someone get re-infected with Hepatitis C? -- Does injecting put you at risk for other types of hepatitis?

    Hepatitis C is a serious liver disease caused by the Hepatitis C virus. About 80% of people who get infected develop a chronic, or lifelong, infection. Over time, chronic Hepatitis C can cause serious health problems including liver damage, liver failure, and even liver cancer. However, some people get only a short term, or acute, infection and are able to clear the virus without treatment. If someone clears the virus, this usually happens within 6 months after first infected.

  • Document Type:
    Pamphlet (or booklet)
  • Collection(s):
    Stephen B. Thacker CDC Library collection
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Improving knowledge, changing attitudes, fostering collaboration : a report on the HIV Prevention Among Injection Drug Users Technical Assistance Project 1998-2005
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). Academy for Educational Development. Center on AIDS & Community Health..
    Published:
    April 2005
    Series:
    IDU/HIV prevention
    Description:
    This is the story of a 6-year project to improve HIV prevention among injection drug users (IDUs), a high-risk and stigmatized group in the United States. : In recent years, the Centers for Disease Control and Prevention (CDC) has worked on a variety...
    File Type:
    Filetype[PDF - 2.54 MB]
  2. Drug Trafficking Routes and Hepatitis B in Injection Drug Users, Manipur, India
    Personal Author:
    Datta, Sibnarayan; Banerjee, Arup; Chandra, Partha K.; Mahapatra, Pradip K.; Chakrabarti, Shekhar; Chakravarty, Runu;
    Published:
    Dec 2006
    Source:
    Emerg Infect Dis. 12(12):1954-1957.
    Description:
    Prevalence of hepatitis B genotype C in injection drug users in the northeastern Indian state of Manipur, neighboring the "Golden Triangle," correlates well with overland drug-trafficking routes, the injection drug use epidemic, and the spread of HIV...
    File Type:
    Filetype[PDF - 314.52 KB]
  3. HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan
    Personal Author:
    Todd, Catherine S.; Abed, Abdullah M.S.; Strathdee, Steffanie A.; Scott, Paul T.; Botros, Boulos A.; Safi, Naqibullah; Earhart, Kenneth C.;
    Published:
    Sep 2007
    Source:
    Emerg Infect Dis. 13(9):1327-1331.
    Description:
    Limited prevalence data for HIV, hepatitis B surface antigen (HBsAg), and hepatitis C virus (HCV) exist for Afghanistan. We studied a cross-sectional sample of adult injection drug users (IDUs) in Kabul, Afghanistan, from June 2005 through June 2006....
    File Type:
    Filetype[PDF - 281.24 KB]
  4. Viral hepatitis and injection drug users
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.). Academy for Educational Development. Center on AIDS & Community Health..
    Published:
    September 2002
    Series:
    IDU/HIV prevention
    Description:
    Millions of Americans have viral hepatitis. It is a particularly significant problem among injection drug users (IDUs). Growing awareness of this problem is leading to new initiatives, but efforts to prevent these diseases and reduce their medical, f...
    File Type:
    Filetype[PDF - 60.38 KB]
  5. MMWR. Morbidity and mortality weekly report, Vol. 50, no. 19, May 18, 2001
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    May 18, 2001
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 50, no. 18
    Description:
    Public Health and Injection Drug Use -- Trends in Injection Drug Use Among Persons Entering Addiction Treatment --New Jersey, 1992-1999 -- Soft Tissue Infections Among Injection Drug Users --San Francisco, California, 1996-2000 -- Update: Syringe Exc...
    File Type:
    Filetype[PDF - 160.35 KB]